GH Research (GHRS) Shares Outstanding (Diluted Average) (2022 - 2025)
GH Research (GHRS) recorded quarterly Shares Outstanding (Diluted Average) of $560.0 in Q3 2025, up 69.7% quarter-over-quarter from $330.0 in Q2 2025, and down 3.45% on a YoY basis from $580.0 in Q3 2024.
GH Research (GHRS) Shares Outstanding (Diluted Average) (2022 - 2025) Analysis & Trends
GH Research's Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $560.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 810.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 92.44 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 560.00 |
| Jun 30, 2025 | 330.00 |
| Mar 31, 2025 | 190.00 |
| Sep 30, 2024 | 580.00 |
| Jun 30, 2024 | 350.00 |
| Mar 31, 2024 | 150.00 |
| Sep 30, 2023 | 470.00 |
| Jun 30, 2023 | 360.00 |
| Mar 31, 2023 | 210.00 |
| Sep 30, 2022 | 110.00 |
| Jun 30, 2022 | 100.00 |